cytostat effect suramin prostat cancer cell primari tumor suramin undergo clinic trial chemotherapeut agent prostat cancer effect suramin cultur human epitheli cell normal benign hyperplast malign prostat tissu serum-fre medium suramin clonal growth prostat cell half-maxim dose micrograms/ml growth inhibit suramin revers hour exposur conjunct suramin cellular phenotyp regard express keratin prostate-specif antigen suramin antagonist growth factor-medi mitogenesi ten-fold excess growth factor cytostat activ suramin comparison activ possibl chemotherapeut agent suramin suboptim inhibitori effect revers cellular phenotyp 